LisaShawMD

PubMed

• Ante mortem CSF tau levels correlate with post mortem tau pathology in FTLD.
  Irwin, D. J.,Lleó, A.,Xie, S. X.,McMillan, C. T.,Wolk, D.,Lee, E. B.,Van Deerlin, V. M.,Shaw, L. M.,Trojanowski, J. Q.,Grossman, M.> ;Ann. Neurol.. 2017 Jul 19
• 38 citations
  Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals
  Ross W. Paterson, Jonathan W. Bartlett, Kaj Blennow, Nick C. Fox, Alzheimer's Disease Neuroimaging Initiative, Leslie M. Shaw, John Q. Trojanowski, Henrik Zetterberg, ...> ;Translational Psychiatry. 2014 Jul 29
• CSF protein biomarkers predicting longitudinal reduction of CSF β-amyloid42 in cognitively healthy elders.
  Mattsson N, Insel P, Nosheny R, Zetterberg H, Trojanowski JQ, Shaw LM, Tosun D, Weiner M> ;Transl Psychiatry. 2013-08-20
• Plasma biomarkers of depressive symptoms in older adults.
  Arnold SE, Xie SX, Leung Y, Wang L, Kling MA, Han X, Kim EJ, Wolk DA, Bennett DA, Chen-Plotkin A, Grossman M, Hu W, Lee VM, Mackin RS, Trojanowski JQ, Wilson RS, Shaw LM> ;Transl Psychiatry. 2012-01-03
• Novel CSF biomarkers for frontotemporal lobar degenerations.
  Hu WT, Chen-Plotkin A, Grossman M, Arnold SE, Clark CM, Shaw LM, McCluskey L, Elman L, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ> ;Neurology. 2010-12-07
• Join now to see all